Related references
Note: Only part of the references are listed.Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer
Hannelore V. Heemers et al.
CANCER RESEARCH (2011)
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Paivi Ostling et al.
CANCER RESEARCH (2011)
Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity
Marianne D. Sadar
CANCER RESEARCH (2011)
Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
Yingming Li et al.
CANCER RESEARCH (2011)
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
Calmodulin Protects Androgen Receptor From Calpain-Mediated Breakdown in Prostate Cancer Cells
Arun Sivanandam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells
Nuria Coll Bastus et al.
CANCER RESEARCH (2010)
Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer
Johannes Hofland et al.
CANCER RESEARCH (2010)
ERK Regulates Calpain 2-induced Androgen Receptor Proteolysis in CWR22 Relapsed Prostate Tumor Cell Lines
Honglin Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Pharmacological Targeting of Constitutively Active Truncated Androgen Receptor by Nigericin and Suppression of Hormone-Refractory Prostate Cancer Cell Growth
Tetsuo Mashima et al.
MOLECULAR PHARMACOLOGY (2010)
Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
Y. Niu et al.
ONCOGENE (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
Mara P. Steinkamp et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
Chunru Lin et al.
CELL (2009)
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Karen E. Knudsen et al.
CLINICAL CANCER RESEARCH (2009)
Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer
Fernand Labrie et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Characterization of nuclear import of the domain-specific androgen receptor in association with the importin α/β and Ran-guanosine 5′-triphosphate systems
Natsuko Kaku et al.
ENDOCRINOLOGY (2008)
Sintokamides A to E, Chlorinated Peptides from the Sponge Dysidea sp that Inhibit Transactivation of the N-Terminus of the Androgen Receptor in Prostate Cancer Cells
Marianne D. Sadar et al.
ORGANIC LETTERS (2008)
Androgen receptor structural and functional elements: Role and regulation in prostate cancer
Scott M. Dehm et al.
MOLECULAR ENDOCRINOLOGY (2007)
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence
Stephen J. Libertini et al.
CANCER RESEARCH (2007)
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions
Monika Jagla et al.
ENDOCRINOLOGY (2007)
Androgen receptor decoy molecules block the growth of prostate cancer
Steven N. Quayle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer
G Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
M Stanbrough et al.
CANCER RESEARCH (2006)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor
AJ Saporita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural analysis of the DNA-binding domain of alternatively spliced steroid receptors
L Wickert et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The putative androgen receptor-A form results from in vitro proteolysis
CW Gregory et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2001)
Share Paper
